On February 14, 2025, the Stochastic Oscillator for FMED moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 21 instances where the indicator left the oversold zone. In of the 21 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
FMED moved above its 50-day moving average on January 21, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for FMED crossed bullishly above the 50-day moving average on January 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FMED advanced for three days, in of 100 cases, the price rose further within the following month. The odds of a continued upward trend are .
FMED may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 72 cases where FMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for FMED moved out of overbought territory on January 31, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 9 similar instances where the indicator moved out of overbought territory. In of the 9 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on February 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on FMED as a result. In of 29 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for FMED turned negative on February 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Category Health
A.I.dvisor indicates that over the last year, FMED has been closely correlated with VHT. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if FMED jumps, then VHT could also see price increases.
Ticker / NAME | Correlation To FMED | 1D Price Change % | ||
---|---|---|---|---|
FMED | 100% | -0.09% | ||
VHT - FMED | 82% Closely correlated | +0.46% | ||
IBB - FMED | 82% Closely correlated | +0.50% | ||
IHI - FMED | 80% Closely correlated | N/A | ||
XBI - FMED | 77% Closely correlated | +0.21% | ||
XLV - FMED | 74% Closely correlated | +0.56% |